Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 31, 2014
Pharmacy Choice - News - Over-the-Counter Drugs - July 31, 2014

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 22 of 22     Go To Page:

7/30/14 - Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 30, 2014/ PRNewswire/ Eisai Inc. and Arena Pharmaceuticals, Inc. announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of Week 52 Weight-Loss Outcomes," was recently
7/30/14 - Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort Topical Spray 0.25%
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro Pharmaceuticals U.S.A., Inc., the owner of the Reference Listed Drug of its filing. On July 28, 2014, Taro filed suit against Perrigo in the United States D
7/30/14 - Pfizer Reports Second-Quarter 2014 Results [Global Data Point]
At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment; the Global Vaccines, Oncology and Consumer Healthcare segment; and the Global Established Pharmaceutical segment.
7/29/14 - Bohai Pharmaceuticals Updates Corporate Website
YANTAI, CHINA/ ACCESSWIRE/ July 28, 2014/ Bohai Pharmaceuticals Group, Inc., a leading manufacturer and marketer of traditional Chinese medicine, today said it has updated its company website to include new corporate and industry information. Bohai Pharmaceuticals Group A manufacturer and marketer of traditional Chinese medicine in the People s
7/29/14 - Chinese Pharmaceutical Market: Forecasts and Outlooks 2014-2024
Medical revenues in China- your guide to trends, companies and potentials What's the outlook for the Chinese pharma market? Can it sustain high growth? China still holds great potential for medicines and their sales.
7/29/14 - Eisai and Arena Pharmaceuticals Announce BELVIQ (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 29, 2014/ PRNewswire/ Eisai Inc. and Arena Pharmaceuticals, Inc. announced today that BELVIQ has been nominated by the Galien Foundation and Awards Committee for the 2014 Prix Galien USA Award in the Best Pharmaceutical Agent category. "The Prix Galien USA Award recognizes the extensive research necess
7/29/14 - Nonprescription Drugs Advisory Committee; Notice of Meeting
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration. Location: FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room, Silver Spring, MD 20993-0002. Information regarding special accommodations due to a disability, visitor parking, and transportation m
7/29/14 - PFIZER REPORTS SECOND-QUARTER 2014 RESULTS
Pfizer Inc. reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment; the Global Vaccines, Oncology and Consumer Healthcare segment; and.
7/28/14 - Exploring the Possibility of Proprietary Name Reservation for Drug Products; Establishment of a Public Docket
During the negotiations for the 2007 reauthorization of the Prescription Drug User Fee Amendments Act, FDA agreed to several performance goals related to the review of drug and biological product proprietary names to reduce medication error. Among those goals, FDA and industry expressed an interest in exploring the possibility of "reserving" propri
7/28/14 - Johnson & Johnson Reports 2014 Second-Quarter Results:
By a News Reporter-Staff News Editor at Diabetes Week Johnson& Johnson announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%. Net earnings and diluted earnings per share for the second quarter o
7/28/14 - Public Citizen to FDA: Over-the-Counter Teething Medications for Infants Should Be Removed from the Market Because of Life-Threatening Reaction
Public Citizen issued the following news release:. The U.S. Food and Drug Administration should not allow over-the-counter benzocaine products to be marketed for treating teething in infants and toddlers because they can prompt a rare but potentially deadly adverse reaction, Public Citizen said today in a petition to the agency. In addition, the ag
7/27/14 - FDA Clears NeuroMetrix Wearable Technology for Over-the-Counter Use in Treatment of Chronic Pain
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA NeuroMetrix, Inc. announced that its wearable technology for treatment of chronic pain received 510 clearance from the U.S. Food and Drug Administration for over-the-counter use. "Patient response to SENSUS, our prescription wearable device for treatment of chronic pain, has
7/27/14 - New strategies for coping with chronic heart failure [The Philadelphia Inquirer :: ]
One possible strategy is taking potassium supplements a practice that appears to reduce mortality, according to a new University of Pennsylvania study. The Food and Drug Administration recently approved a wireless implantable device so physicians can keep tabs on the pressure in their patients' pulmonary arteries a device tested at Einstein Med
7/25/14 - CLSN's Dignity At Work, GSK's Flonase To Go OTC, MGNX Hits Second Dart
LONDON- A regulatory application for malaria vaccine candidate, RTS, S, submitted to the European Medicines Agency by GlaxoSmithKline plc has been accepted for review, thus becoming the world's first malaria vaccine candidate to undergo regulatory review. AGEN rose 11.15% to close Thursday's trading at $3.39. Cynosure Inc.' s flagship product PicoS
7/25/14 - United Kingdom,United States : FDA approves Flonase allergy relief for sale over-the-counter in the United States [TendersInfo (India)]
GlaxoSmithKline plc today announced that the U.S. Food and Drug Administration has approved Flonase Allergy Relief, containing the No. 1 prescribed allergy treatment ingredient, as an over-the-counter treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies. Roughly 50 million people in the United States suffer
7/24/14 - Back to the dark ages of medicine ; The government's top doctor says antibitoic resistance is as great a threat as terrorism. Lisa Salmon reports on... [Newcastle Journal (England)]
Back to the dark ages of medicine; The government's top doctor says antibitoic resistance is as great a threat as terrorism. Lisa Salmon reports on the rise of superbugs. It's estimated that drug- resistant strains of bacteria are responsible for 5,000 deaths a year in the UK and 25,000 it's estimated that drug-resistant strains of bacteria are res
7/24/14 - BRISTOL MYERS SQUIBB CO - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In July 2014, the Company announced that the Japanese Ministry of Health, Labor and Welfare approved Daklinza and Sunvepra for Japan's first all-oral, interferon- and ribavirin-free treatment regimen for patients with genotype 1 chronic hepatitis C virus infection, particularly those with compensated cirrhosis. In July 2014, the Company and Ono...
7/24/14 - FDA Approves Flonase Allergy Relief For Sale Over-The-Counter In The United States
GlaxoSmithKline plc today announced that the U.S. Food and Drug Administration has approved Flonase Allergy Relief, containing the No. 1 prescribed allergy treatment ingredient 1, as an over-the-counter treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies. 2. Roughly 50 million people in the United States
7/24/14 - Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance
MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to medication non-adherence and hospital readmission rates specified in a study published in a recent issue of the Annals of Inter
7/24/14 - Nutra Pharma Announces Infrastructure Improvements to Handle Increased Sales
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy, HIV and Multiple Sclerosis, is announcing that they are in the process of completing critical capital improvements to their warehouse and fulfillment center in order to meet increased demand and shipments of their over-the-counter pain reliever,..
7/24/14 - Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%
Perrigo Company today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration for its previously approved New Drug Application for testosterone gel 1.0%. FDA concluded that Perrigo's testosterone product is therapeutically equivalent to AndroGel 1% and can be substituted with the full expectat
7/24/14 - Serenus Biotherapeutics Strengthens Leadership With Appointments to Board and Management
Nigel Fleming, founder and former Chairman of Athena Diagnostics; and Kazuhiro Umeda, former President of JAIC Singapore, Indonesia, and Thailand. It named Moosa Areff, who most recently served as CEO of Ranbaxy South Africa's Sonke Pharmaceuticals subsidiary, as its Chief Operating Officer. Mr. Luthuli noted that the appointments come as the Sub-S
Articles(s): 1 - 22 of 22     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
West Virginia Best Practice Prescribing & Drug Diversion Training
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415